Classer les publications sur l'année
-
Ăconomie de la santĂ©
Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals
LE MONNIER A, DUBURCQ A, ZAHAR JR, CORVEC S, GUILLARD T, CATTOIR V, WOERTHER PL, FIHMAN V, LALANDE V, JACQUIER H, MIZRAHI A, FARFOUR E, MORAND P, MARCADĂ G, COULOMB S, TORRETON E, FAGNANI F, BARBUT F, GMC STUDY GROUP
J Hosp Infect ; 2015;91:117-122
-
Ăconomie de la santĂ©
Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study.
DARBĂ J, KASKENS L, DETOURNAY B, KERN W, NICOLUCCI A, OROZCO-BELTRAN D, RAMIREZ DE ARELLANO A
ClinicoEconomics and Outcomes Research ; 2015;7:163-171
-
Santé publique
Bouge ta santĂ© Ă Clichy-sous-Bois » : une approche intersectorielle de lâactivitĂ© physique
CZAPLICKI G, DONIO V, NOSSEREAU C, FIKOJEVIC M, RICHARD D
Santé publique ; 2016;28 (supp.1) : 175-8
-
Santé publique
Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.
FAGNANI F, PHAM T, CLAUDEPIERRE P, BERENBAUM F, DE CHALUS T, SAADOUN C, JOUBERT JM, FAUTREL B.
J Med Econ ; 2016;25:1-10
-
Pharmaco-Epidémiologie
Prevalence of Gout in the Adult Population of France.
BARDIN T, BOUEE S, CLERSON P, CHALES G, FLIPO RM, LIOTE F, PEREZ V, POIRAUD T, SCHAEVERBEKE T, RICHETTE P.
Arthritis Care Res ; 2016;68(2):261-6
-
Pharmaco-Epidémiologie
Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.
BOUEE S, EMERY C, SAMSON A, GOURMELEN J, BAILLY C, COTTE FE.
Thromb J. ; 2016;14(4)
-
Pharmaco-Epidémiologie
Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.
PHILIPPE F, BLIN P, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.
Value Health ; 2015;18(7):A382
-
Ăconomie de la santĂ©
Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.
BLIN P, PHILIPPE F, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.
Value Health ; 2015;18(7):A386
-
Biométrie et Analyses de bases de données/SNDS
Anemia Management Practice in French Hemodialysis Centers.
ROTTEMBOURG J, URENA TORRES P, LE MONIES DE SAGAZAN H, SIRAJEDINE K, EMERY C, ZAKIN L, WERNLI J, MAHI L.
Br J Med Med Res ; 2015;5(11):1338-1348
-
Ăconomie de la santĂ©
Utilisation de lâinsuline en France : les chiffres clĂ©s
DETOURNAY B
Diabétologie Pratique - congrÚs 1er avril 2015 ;
-
Ăconomie de la santĂ©
Prise en charge et coûts de la bronchopneumopathie chronique obstructive en France en 2011
LAURENDEAU C, CHOUAID C, ROCHE N, TERRIOUX P, GOURMELEN J , DETOURNAY B
Rev Mal Respir ; 2015;32:682-91
-
Biométrie et Analyses de bases de données/SNDS
Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database
RAFFI F, YAZDANPANAH Y, FAGNANI F, LAURENDEAU C, LAFUMA A, GOURMELEN J
J Antimicrob Chemother ; 2015;70:2121-2128
-
Ăconomie de la santĂ©
Le coĂ»t de lâinsulinothĂ©rapie en France chez les patients diabĂ©tiques de type 2
DETOURNAY B, BUREAU I, GOURMELEN J
MĂ©decine des maladies MĂ©taboliques ; 2015;9:3S30-3S33
-
Pharmaco-Epidémiologie
Impact of socioeconomic status on health and quality of care in adults with type 2 diabetes in France: the Entred 2007 study
FOSSE-EDORH S, FAGOT-CAMPAGNA A, DETOURNAY B, BIHAN H, ESCHWEGE E, GAUTIER A, DRUET C
Diabet Med ; 2015;32(11):1438-1444
-
Biométrie et Analyses de bases de données/SNDS
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database
DETOURNAY B, HALIMI S, ROBERT J, DESCHASEAUX C, DEJAGER S
Vasc Health Risk Manag ; 2015;11:417-25
  Â